Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial
文献类型：期刊论文
| 作者 | Zuo, Jing2; Duan, Wei3; Zhao, Mingxuan4; Chen, Zhendong5; Lin, Jie6; Shi, Huaqiu7; Jiang, Ou8; Zhang, Youzhong9; Fang, Meiyu10; Wang, Li11 |
| 刊名 | CANCER COMMUNICATIONS
 |
| 出版日期 | 2024-07-23 |
| DOI | 10.1002/cac2.12578 |
| 通讯作者 | Wu, Lingying(wulingying@csco.org.cn) |
| WOS关键词 | PEMBROLIZUMAB |
| 资助项目 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| WOS记录号 | WOS:001275028000001 |
| 出版者 | WILEY |
| 资助机构 | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/137292]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Wu, Lingying |
| 作者单位 | 1.CSPC Pharmaceut Grp Co Ltd, Shijiazhuang, Hebei, Peoples R China 2.Chinese Acad Med Sci & Peking Union Med Coll, Dept Gynecol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Pan Jia Yuan South Lane, Beijing 100021, Peoples R China 3.Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Gynecol Oncol, Beijing, Peoples R China 4.Third Peoples Hosp Kunming, Yunnan Clin Ctr Infect Dis, Dept Hepatol 1, Kunming, Peoples R China 5.Second Affiliated Hosp Anhui Med Univ, Dept Oncol, Hefei, Anhui, Peoples R China 6.Second Affiliated Hosp Kunming Med Univ, Dept Dermatol & Venereol, Kunming, Yunnan, Peoples R China 7.First Affiliated Hosp Gannan Med Univ, Dept Oncol, Ganzhou, Peoples R China 8.Second Peoples Hosp Neijiang, Dept Pathol, Neijiang, Sichuan, Peoples R China 9.Qilu Hosp Shandong Univ, Dept Gynecol, Jinan, Shandong, Peoples R China 10.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Rare & Head & Neck Oncol, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zuo, Jing,Duan, Wei,Zhao, Mingxuan,et al. Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial[J]. CANCER COMMUNICATIONS,2024. |
| APA | Zuo, Jing.,Duan, Wei.,Zhao, Mingxuan.,Chen, Zhendong.,Lin, Jie.,...&Wu, Lingying.(2024).Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.CANCER COMMUNICATIONS. |
| MLA | Zuo, Jing,et al."Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial".CANCER COMMUNICATIONS (2024). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。